Indiana Medical Scientist/Engineer Training Program

印第安纳州医学科学家/工程师培训计划

基本信息

项目摘要

Abstract The Indiana University School of Medicine (IUSM) Medical Scientist/Engineer Training Program (MSTP) has trained a diverse cohort of physician-scientists/engineers to conduct rigorous, innovative and clinically relevant research. Graduates are leaders in the biomedical sciences who are applying the rapid advances in scientific discovery to the development of new treatments for human disease. We aim to partner with NIGMS to support this program, requesting that 25% of our cohort be trainees on the T32 grant. Our Specific Aims are 1) to recruit a competitive cohort from diverse backgrounds who have a strong commitment both to research and to patient care; 2) to train students in basic and translational research and in medicine, thus equipping graduates to succeed; and 3) to graduate students with MD and PhD degrees who are competitive for the best residency positions; and who will become leading, innovative physician-scientists/physician-engineers in academics and industry. A unique aspect of our MSTP is its long-standing partnership and synergy with the Weldon School of Biomedical Engineering (BME) at Purdue University; the program has already graduated 20 physician-engineers. A second key feature is our focus on diversity, equity, and inclusion (DEI). In this regard, our many active recruitment and feeder programs, including one supported by a new Burroughs-Wellcome Fund grant, have made us leaders in DEI recruitment, particularly in the Midwest. In the last five years 22% of our matriculants have come from underrepresented and/or disadvantaged groups, and 50% have been women. We have 108 preceptors with strong training and research records and ~$130 million in grant support. The program’s excellence is reflected in the increase in applications, from 99 in 2007 to 293 in 2021. The MSTP is the top training priority for IUSM, funded with $2 million in direct support and several MSTP-specific endowments, including $10 million from the Eli Lilly Foundation. Our program equips students to excel by providing superior programmatic structure, curricular content, mentorship, research facilities and clinical resources. IUSM is Indiana’s only allopathic medical school: it is the largest medical school in the nation, with one of the largest health systems. Our leaders prioritize student welfare, DEI training and safety. Training is required in the responsible conduct of research and in research reproducibility and all graduates have published first author papers. In the last five years, 100% of our graduates matched into top-ranked residency programs across the nation, including research-intensive residencies (e.g., PSTPs). Long term, graduates are successful in academics and in industry. Here, we propose to partner with NIH to train the next generation of exceptional physician-scientists and physician-engineers in Indiana.
抽象的 印第安纳大学医学院 (IUSM) 医学科学家/工程师培训计划 (MSTP) 培训了一支多元化的医师科学家/工程师队伍,以进行严格、创新和临床相关的研究 研究。毕业生是生物医学领域的领导者,他们正在应用科学的快速进步 发现以开发人类疾病的新疗法。我们的目标是与 NIGMS 合作以支持 该计划要求我们队列中 25% 的人成为 T32 补助金的实习生。我们的具体目标是 1) 招募 来自不同背景的竞争群体,他们对研究和患者都有坚定的承诺 关心; 2)培养基础研究、转化研究和医学方面的学生,从而使毕业生能够 成功; 3)具有MD和PhD学位且有竞争力获得最佳住院医师资格的研究生 职位;谁将成为学术和领域领先的、创新的医师科学家/医师工程师 行业。我们的 MSTP 的一个独特之处在于它与韦尔登学院的长期合作伙伴关系和协同作用 普渡大学生物医学工程(BME);该项目已有 20 名医师兼工程师毕业。 第二个关键特征是我们注重多样性、公平性和包容性 (DEI)。对此,我们许多积极的 招聘和支线计划,包括一项由新的 Burroughs-Wellcome 基金拨款支持的计划, 使我们成为 DEI 招聘领域的领导者,特别是在中西部。过去五年,我们 22% 的预科生 来自代表性不足和/或弱势群体,其中 50% 是女性。我们有108个 导师们拥有丰富的培训和研究记录以及约 1.3 亿美元的赠款支持。该计划的 卓越体现在申请数量的增加上,从 2007 年的 99 个增加到 2021 年的 293 个。MSTP 名列前茅 IUSM 的培训优先事项,由 200 万美元直接支持和多项 MSTP 特定捐赠资助, 其中包括来自礼来基金会的 1000 万美元。我们的课程通过提供卓越的课程来帮助学生取得优异的成绩 计划结构、课程内容、指导、研究设施和临床资源。 IUSM 是 印第安纳州唯一的对抗疗法医学院:它是全国最大的医学院,也是最大的医学院之一 卫生系统。我们的领导者优先考虑学生福利、DEI 培训和安全。需要进行培训 负责任的研究行为和研究可重复性,所有毕业生都发表了第一作者的文章 文件。在过去的五年里,我们的毕业生 100% 匹配到了全美排名靠前的住院医师项目 国家,包括研究密集型住院医师实习(例如,PSTP)。从长远来看,毕业生将在以下方面取得成功 学术界和工业界。在此,我们建议与 NIH 合作,培养下一代杰出人才 印第安纳州的医师科学家和医师工程师。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Benjamin Gaston其他文献

Benjamin Gaston的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Benjamin Gaston', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10457991
  • 财政年份:
    2021
  • 资助金额:
    $ 92.89万
  • 项目类别:
Airway pH regulation in asthma
哮喘气道 pH 值调节
  • 批准号:
    10662247
  • 财政年份:
    2021
  • 资助金额:
    $ 92.89万
  • 项目类别:
Scientific innovation for personalized severe asthma management
个性化重症哮喘管理的科学创新
  • 批准号:
    10269966
  • 财政年份:
    2021
  • 资助金额:
    $ 92.89万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10269967
  • 财政年份:
    2021
  • 资助金额:
    $ 92.89万
  • 项目类别:
Airway pH regulation in asthma
哮喘气道 pH 值调节
  • 批准号:
    10269973
  • 财政年份:
    2021
  • 资助金额:
    $ 92.89万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10662236
  • 财政年份:
    2021
  • 资助金额:
    $ 92.89万
  • 项目类别:
Scientific innovation for personalized severe asthma management
个性化重症哮喘管理的科学创新
  • 批准号:
    10662235
  • 财政年份:
    2021
  • 资助金额:
    $ 92.89万
  • 项目类别:
Scientific innovation for personalized severe asthma management
个性化重症哮喘管理的科学创新
  • 批准号:
    10457990
  • 财政年份:
    2021
  • 资助金额:
    $ 92.89万
  • 项目类别:
Airway pH regulation in asthma
哮喘气道 pH 值调节
  • 批准号:
    10457997
  • 财政年份:
    2021
  • 资助金额:
    $ 92.89万
  • 项目类别:
Sudaxine as an analgesia sparing respiratory stimulant for use in critical care
Sudaxine 作为一种镇痛、省呼吸兴奋剂,用于重症监护
  • 批准号:
    10505268
  • 财政年份:
    2020
  • 资助金额:
    $ 92.89万
  • 项目类别:

相似海外基金

Training the Next Generation of Social and Behavioral Physician-Scientists in ADRD: The Indiana ADRD Medical Scientist Training Program
培训 ADRD 领域的下一代社会和行为医师科学家:印第安纳州 ADRD 医学科学家培训计划
  • 批准号:
    10687172
  • 财政年份:
    2021
  • 资助金额:
    $ 92.89万
  • 项目类别:
Training the Next Generation of Social and Behavioral Physician-Scientists in ADRD: The Indiana ADRD Medical Scientist Training Program
培训 ADRD 领域的下一代社会和行为医师科学家:印第安纳州 ADRD 医学科学家培训计划
  • 批准号:
    10493394
  • 财政年份:
    2021
  • 资助金额:
    $ 92.89万
  • 项目类别:
Training the Next Generation of Social and Behavioral Physician-Scientists in ADRD: The Indiana ADRD Medical Scientist Training Program
培训 ADRD 领域的下一代社会和行为医师科学家:印第安纳州 ADRD 医学科学家培训计划
  • 批准号:
    10340047
  • 财政年份:
    2021
  • 资助金额:
    $ 92.89万
  • 项目类别:
Indiana Medical Monitoring Project
印第安纳州医疗监测项目
  • 批准号:
    8994325
  • 财政年份:
    2015
  • 资助金额:
    $ 92.89万
  • 项目类别:
Indiana Medical Scientist/Engineer Training Program
印第安纳州医学科学家/工程师培训计划
  • 批准号:
    7434738
  • 财政年份:
    2008
  • 资助金额:
    $ 92.89万
  • 项目类别:
Indiana Medical Scientist/Engineer Training Program
印第安纳州医学科学家/工程师培训计划
  • 批准号:
    9096193
  • 财政年份:
    2008
  • 资助金额:
    $ 92.89万
  • 项目类别:
Indiana Medical Scientist/Engineer Training Program
印第安纳州医学科学家/工程师培训计划
  • 批准号:
    7645652
  • 财政年份:
    2008
  • 资助金额:
    $ 92.89万
  • 项目类别:
Indiana Medical Scientist/Engineer Training Program
印第安纳州医学科学家/工程师培训计划
  • 批准号:
    8414290
  • 财政年份:
    2008
  • 资助金额:
    $ 92.89万
  • 项目类别:
Indiana Medical Scientist/Engineer Training Program
印第安纳州医学科学家/工程师培训计划
  • 批准号:
    8287569
  • 财政年份:
    2008
  • 资助金额:
    $ 92.89万
  • 项目类别:
Indiana Medical Scientist/Engineer Training Program
印第安纳州医学科学家/工程师培训计划
  • 批准号:
    8100503
  • 财政年份:
    2008
  • 资助金额:
    $ 92.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了